Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03027466 · ClinicalTrials.gov registry record · NA

Integrating Use of Self-Affirmation Content Into a Mobile App to Promote Quit Attempts With Text-Based Smoking Cessation Intervention Messaging

A NA study, sponsored by National Cancer Institute (NCI).

Completed
Registry status
NA
Development phase
7,899
Enrollment target

NCT03027466: Completed NA study, sponsored by National Cancer Institute (NCI).

NCT03027466 is a NA study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 7,899 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03027466, a NA study, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
NA
Development phase
7,899 participants
Enrollment target

Study Summary

Background: Quitting smoking is hard. It is easy to relapse. Smokers may think of temptation to smoke as a threat if they think it suggests that they are unable to meet the challenges of stopping. When people feel such a threat to their sense of self-identity, they may get defensive. They may want to downplay the importance of quitting. This could make them try to quit less. Self-affirmation is a process of focusing on strengths and values. This can offset threats to the self and promote healthier behavior. Objective: To explore people s values, smoking attitudes, and smoking behavior. Eligibility: People ages 18 and older who smoke Design: The study takes place entirely on a mobile device. Participants will give their age, gender, data about their smoking habits, and desired quit date. Then they will get different texts about quitting. Participants will answer follow-up surveys 1 and 3 months later. ...

Interventions

  • BEHAVIORAL Self-affirmation induction

Trial Details

FieldValue
Enrollment Target 7,899 participants
Start Date 2018-03-06
Est. Completion 2019-09-01
Phase NA

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT03027466

The ClinicalTrials.gov registry entry for NCT03027466 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7,899 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Self-affirmation induction is the first listed.

NCT03027466 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03027466 about?

NCT03027466 is a clinical study titled "Integrating Use of Self-Affirmation Content Into a Mobile App to Promote Quit Attempts With Text-Based Smoking Cessation Intervention Messaging". Background: Quitting smoking is hard. It is easy to relapse. Smokers may think of temptation to smoke as a threat if they think it suggests that they are unable to meet the challenges of stopping. When people feel such a threat to their sense of self-identity, they may get defensive. They may want ...

What is the current status of trial NCT03027466?

This trial is currently completed. It is a NA study. The enrollment target is 7,899 participants. The study started on 2018-03-06. Estimated completion is 2019-09-01.

What interventions are being tested in trial NCT03027466?

The interventions under investigation include: Self-affirmation induction (BEHAVIORAL).

Who is sponsoring clinical trial NCT03027466?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.